MedPath

Epinephrine

Generic Name
Epinephrine
Brand Names
Adrenalin, Allerject, Anapen, Articadent, Astracaine, Auvi-Q, Citanest, Citanest Forte, Emerade, Epipen, Lignospan, Marcaine, Marcaine With Epinephrine, Octocaine, Octocaine With Epinephrine, Orabloc, Scandonest, Sensorcaine, Sensorcaine With Epinephrine, Septanest, Septocaine, Symjepi, Ultacan, Ultracaine, Vivacaine, Xylocaine, Xylocaine With Epinephrine, Zorcaine, Eurneffy
Drug Type
Small Molecule
Chemical Formula
C9H13NO3
CAS Number
51-43-4
Unique Ingredient Identifier
YKH834O4BH
Background

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection.

In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Indication

Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock .

Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics .

In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath . It is also used for the maintenance of mydriasis during intraocular surgery .

Associated Conditions
Anaphylaxis, Angioneurotic Edema, Bleeding, Bronchospasm, Complete Heart Block, Hypotension, Idiopathic Anaphylaxis, Laryngotracheobronchitis, Mild Intermittent Asthma, Nasal Congestion, Open Angle Glaucoma (OAG), Respiratory Distress, Severe Asthma, Syncope, Type I Hypersensitivity, Urticaria, Uterine Contractions, Ventricular Fibrillation, Resuscitation in cardiac arrest following anesthetic accidents, Severe hypersensitivity reactions, Unresponsive Asystole, Unresponsive Bradycardia

Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares

Phase 2
Completed
Conditions
Urticaria
Interventions
Drug: Placebo
First Posted Date
2022-08-11
Last Posted Date
2024-07-30
Lead Sponsor
ARS Pharmaceuticals, Inc.
Target Recruit Count
24
Registration Number
NCT05496465
Locations
🇺🇸

Bernstein Clinical Research Center, LLC, Cincinnati, Ohio, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

The Effect of Epinephrine, Norepinephrine and Phenylephrine on Intraoperative Hemodynamic Performance

Phase 4
Recruiting
Conditions
Cardiac Output, Low
Cardiac Output, High
Perfusion; Complications
Interventions
First Posted Date
2022-08-09
Last Posted Date
2022-10-19
Lead Sponsor
Medical University of Vienna
Target Recruit Count
225
Registration Number
NCT05492968
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Opioid-Free Pain Protocol After Shoulder Arthroplasty

First Posted Date
2022-08-05
Last Posted Date
2025-02-17
Lead Sponsor
Henry Ford Health System
Target Recruit Count
80
Registration Number
NCT05488847
Locations
🇺🇸

Henry Ford Health, Detroit, Michigan, United States

Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension

Phase 4
Completed
Conditions
Pulmonary Arterial Hypertension
Interventions
First Posted Date
2022-06-30
Last Posted Date
2022-08-05
Lead Sponsor
Stanford University
Target Recruit Count
15
Registration Number
NCT05439460
Locations
🇺🇸

Cardiac Catheterization Lab,Stanford University Medical Center, Stanford, California, United States

Comparison of the Effects of Two Concentrations of Adrenaline (0.33 mg/l vs 1 mg/l) in the Irrigation Serum of Arthroscopic Shoulder Surgery

Not Applicable
Completed
Conditions
Shoulder Rotator Cuff Tendinitis
Interventions
First Posted Date
2022-06-30
Last Posted Date
2024-07-01
Lead Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Target Recruit Count
181
Registration Number
NCT05439213
Locations
🇫🇷

Clinique de l'Atlantique, Puilboreau, France

Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery

First Posted Date
2022-06-10
Last Posted Date
2022-06-10
Lead Sponsor
University of Puerto Rico
Target Recruit Count
100
Registration Number
NCT05413902
Locations
🇵🇷

Puerto Rico Medical Center - University District Hospital, San Juan, Puerto Rico

Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
First Posted Date
2022-05-06
Last Posted Date
2024-07-30
Lead Sponsor
ARS Pharmaceuticals, Inc.
Target Recruit Count
18
Registration Number
NCT05363670
Locations
🇺🇸

University of South Florida, Tampa, Florida, United States

🇺🇸

Bernstein Clinical Research Center, LLC, Cincinnati, Ohio, United States

🇺🇸

Institute for Asthma and Allergy, Chevy Chase, Maryland, United States

and more 1 locations

Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial

Phase 2
Conditions
Hypotension
Interventions
First Posted Date
2022-04-14
Last Posted Date
2024-04-23
Lead Sponsor
Boston Children's Hospital
Target Recruit Count
86
Registration Number
NCT05327556
Locations
🇺🇸

Boston Children's Hospital, Boston, Massachusetts, United States

Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty

Phase 2
Completed
Conditions
Postoperative Pain
Total Knee Arthroplasty
Interventions
First Posted Date
2022-04-13
Last Posted Date
2022-04-14
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
146
Registration Number
NCT05324995
Locations
🇮🇷

Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Phase 4
Completed
Conditions
Eyelid Abscess
Eyelid Papilloma
Eyelid Boil
Eyelid Tumor
Eyelid Bump
Eyelid Deformity
Anesthesia, Local
Ophthalmology
Interventions
Drug: 0.9% Bacteriostatic Local Anesthetic Injection
Procedure: Eyelid Lesion Removal
First Posted Date
2022-03-24
Last Posted Date
2023-12-29
Lead Sponsor
University of California, San Francisco
Target Recruit Count
95
Registration Number
NCT05294640
Locations
🇺🇸

University of California at San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath